Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03943758
Other study ID # Low-residue
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 10, 2019
Est. completion date December 31, 2020

Study information

Verified date December 2021
Source Changhai Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Previous researches demonstrated that a prepackaged low-residue diet (LRD) could achieve better bowel preparation quality compared with a self-prepared LRD. However, up to now, there has been no widely acceptable standard of LRD for bowel preparation. Moreover, these prepackaged LRD adopted in previous studies mainly consisted of traditional foods without further processing. Recently, a prepackaged LRD for Special Medical Purpose was specifically designed for bowel preparation. This trail was to compare the impact of the prepackaged LRD on bowel preparation for colonoscopy with self-prepared LRD by patients.


Recruitment information / eligibility

Status Completed
Enrollment 589
Est. completion date December 31, 2020
Est. primary completion date December 10, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patients whose age is between 18-65. - Patients who have indications for screening, surveillance and diagnostic colonoscopy. - Patients who have signed inform consent form Exclusion Criteria: - subjects who had known or suspected heart failure, stroke or renal failure; - subjects who had a history of colon surgery or inflammatory bowel disease; - subjects who Patients with had digestion or absorption dysfunction or any dietary restriction due to various reasons; - subjects who had a history of hypersensitivity to any ingredients of laxatives or soy products; - subjects who had high risk factors for bowel preparation such as chronic constipation, Body Mass Index (BMI) greater than 30 or BMI less than 18 Kg/m2, diabetes, spinal cord injury, or use of medications affecting bowel motility within a week; - subjects who had participated in another interventional clinical trial in the previous 60 days; - pregnant or lactating women and those planning to become pregnant.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Prepackaged Low-residue diet
Subjects in the prepackaged Low-residue diet group were given 6 packs (60g/pack) pre-packaged formula LRD and asked to use the formula according to individual needs prior to colonoscopy.
Self-prepared Low-residue diet
Subjects in the self-prepared Low-residue diet group were instructed to follow and prepare an Low-residue diet in the day prior to colonoscopy.

Locations

Country Name City State
China Changhai Hospital, Second Military Medical University Shanghai

Sponsors (8)

Lead Sponsor Collaborator
Changhai Hospital First Affiliated Hospital, Sun Yat-Sen University, Jinan Military General Hospital, Qilu Hospital of Shandong University, The First Affiliated Hospital with Nanjing Medical University, West China Hospital, Wuhan TongJi Hospital, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adequate bowel preparation rate Boston Bowel Preparation Scale (BBPS) was adopted to evaluate the quality of bowel preparation. Each section of the colon (i.e. the right, the transverse, and the rectosigmoid colon) was rated (0, very poor; 1, poor; 2, good; and 3, very good). Adequate bowel of bowel preparation was defined as a total score = 6 and all colon segments BBPS = 2. Inadequate bowel preparation was defined as any colon segment BBPS = 1. 30 mins
Primary BBPS scores of the entire colon The sum of the scores of three bowel segment. 30 mins
Secondary adenoma detection rate (ADR) adenoma detection rate is the number of patients with at least one adenoma, divided by the total number of patients. 30 mins
Secondary preparation completion rate preparation completion rate is the number of patients ingest more than 80% laxative, divided by the total number of patients. 1 day
See also
  Status Clinical Trial Phase
Completed NCT04192565 - A Prospective Investigation of the ColubrisMX ELS System N/A
Recruiting NCT04516785 - Reducing Colonoscopies in Patients Without Significant Bowel Disease
Recruiting NCT05381792 - Serial Gut Microbiome and Bacterial Gene Markers Changes After Endoscopic Resection of Colorectal Advanced Neoplasia
Withdrawn NCT05606081 - Predicting Risk for Post-polypectomy Colorectal Cancer N/A
Recruiting NCT05576506 - Application of Hyperspectral Imaging Analysis Technology in the Diagnosis of Colorectal Cancer Based on Colonoscopic Biopsy
Active, not recruiting NCT03796884 - Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer Phase 2
Completed NCT05508503 - A Study on a Blood-based Dual-target Test for CRC Detection
Recruiting NCT02935049 - Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid Technique N/A
Completed NCT05477836 - Feasibility and Safety of MiWEndo-assisted Colonoscopy N/A
Active, not recruiting NCT05740137 - Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy N/A
Active, not recruiting NCT05754229 - Accuracy of Real Time Characterization in Artificial Intelligence-assisted Colonoscopy N/A
Completed NCT03234725 - Analysis of New Endoscopic Features and Variable Stiffness in Colonoscopy: Prospective Randomised Trial
Completed NCT05913453 - Technical Failure During Colorectal Endoscopic Full Thickness Resection (EFTR): The "Through Thick and Thin" Study
Recruiting NCT05261932 - Research on Endoscopic Precision Biopsy.
Completed NCT02521727 - To Investigate Risk of Colorectal Neoplasms in First-degree Relatives of Patients With Non-advanced Adenomas
Completed NCT02226185 - Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence Phase 2/Phase 3
Completed NCT00298545 - Effect of Vitamin D and Calcium on Genes in the Colon Phase 1
Completed NCT03268655 - Ginger and Gut Microbiome (GINGER) N/A
Active, not recruiting NCT04952129 - Optimal Selenium for Bowel Polyps (OSCAR) Phase 1
Recruiting NCT04444908 - Development and Validation of an Artificial Intelligence-assisted Strategy Selection System for Colonoscopy Cleaning